Research from Jan Terje Andersen’s group on biological medicines during pregnancy has received international attention. The recently published study has been highlighted by Nature and has also received coverage from two major Norwegian news outlets, NRK and VG.
Revolutionary immunotherapy offers hope to cancer patients who previously had no treatment options.
Oslo University Hospital (OUS) and UCB have established a strategic research collaboration focused on advancing specific key aspect of antibody functionality while preserving a broad range of other critical antibody properties.
Launch of the IMPACT project to develop the first antibody-based countermeasure for orthopoxviruses
What do Avengers, true crime podcasts and machine learning have in common? At Pint of Science, PRIMA postdocs Nicholas Chandler and Nikoline L. Rasmussen presented their research on harnessing the full potential of our body’s cancer-killing cells.
Postdoc Madeleine Lehander has been awarded a PRIMA Synergy Grant to develop faster and safer adoptive T cell therapies by targeting memory T cells, in collaboration with researcher Hassen Kared.
Postdoc Karine Flem Karlsen receives a PRIMA synergy grant together with postdoc Alenka Djarmila Behsen to develop the RE-FUEL platform aimed at improving T and NK cell persistence in the tumor microenvironment
PRIMA Centre Director Karl-Johan Malmberg is elected as a member of the Norwegian Academy of Science and Letters (DNVA) - a non-governmental, nationwide body founded in 1857 that embraces all fields of science with the purpose to support the advancement of science and scholarship in Norway.
PRIMA publishes the 2025 Annual Report highlighting a year of impact and innovation
Six new projects have been admitted to UiO:Life Science's innovation programme for health-related life sciences, SPARK Norway. The teams will develop their ideas to products and solutions benefiting patients and society.
